NOVEL COMBINATION BETWEEN 8-CYCLOPROPYL-3-[2-(3-FLUOROPHENYL) ETHYL]-7,8-DIHYDRO-3H-[1,3]OXAZINO[6,5-G][1,2,3]BENZOTRIAZINE-4,9-DIONEAND AN ACETYLCHOLINESTERASE INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
Medicinal products containing the same which are useful in treating cognitive disorders associated with cerebral ageing and with neurodegenerative diseases.